Embryo-Derived Cathepsin B Promotes Implantation and Decidualization by Activating Pyroptosis
- Adv Sci (Weinh). 2024 Nov;11(43):e2402299. doi: 10.1002/advs.202402299.
- 1. Key Laboratory of Animal Genetics, Breeding and Reproduction in the Plateau Mountain Region, College of Animal Science, Guizhou University, Guiyang, 550025, China.
- 2. College of Veterinary Medicine, South China Agricultural University, Guangzhou, 510642, China.
- 3. Center for Reproductive Medicine and Obstetrics and Gynecology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, 210008, China.
Embryo implantation and decidualization are crucial for a successful pregnancy. How the inflammatory response is regulated during these processes is undefined. Pyroptosis is an inflammatory form of cell death mediated by gasdermin D (GSDMD). Through in vivo, cultured epithelial cells and organoids, it is shown that Pyroptosis occurs in epithelial cells at the implantation site. Compared with those on day 4 of pseudopregnancy and delayed implantation, pyroptosis-related protein levels are significantly increased on day 4 of pregnancy and activated implantation, suggesting that blastocysts are involved in regulating Pyroptosis. Blastocyst-derived Cathepsin B (CTSB) is stimulated by preimplantation estradiol-17β and induces Pyroptosis in epithelial cells. Pyroptosis-induced IL-18 secretion from epithelial cells activates a disintegrin and metalloprotease 12 (ADAM12) to process the Epiregulin precursor into mature Epiregulin. Epiregulin (EREG) enhances in vitro decidualization in mice. Pyroptosis-related proteins are detected in the mid-secretory human endometrium and are elevated in the recurrent implantation failure endometrium. Lipopolysaccharide treatment in pregnant mice causes implantation failure and increases pyroptosis-related protein levels. Therefore, the data suggest that modest Pyroptosis is beneficial for embryo implantation and decidualization. Excessive Pyroptosis can be harmful and lead to pregnancy failure.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Cancer
-
target: NOD-like Receptor (NLR)Research Areas: Inflammation/Immunology
-
Cat. No.Product NameCategory/Application